New Medicine Service (NMS)

The New Medicine Service (NMS) was the fourth Advanced Service to be added to the NHS community pharmacy contract; it commenced in the beginning of October 2011.

The service provides support for people with long-term conditions newly prescribed a medicine to help improve medicines adherence; it is initially focused on particular patient groups and conditions.

Download the updated NMS service specification

CPGM New Medicines Service (NMS) toolkit – January 2024

In order to support you, CPGM have also produced a of toolkit containing key information to help you.

The toolkit outline what you need to do to meet the service specification requirements and is a great tool to help you identify any knowledge gaps so you can focus your future continuing professional development.

New Medicine Service (NMS) Expansion

As part of negotiations for Year 3 of the Community Pharmacy Contractual Framework (CPCF) it has been agreed that the New Medicine Service (NMS) it to be expanded. The service enables pharmacy staff to offer support to patients when dealing with their newly prescribed medications for a range of conditions

As of 1st September, an additional 13 conditions have been added to the list of illness that pharmacies are able to offer this type of support relating to. The conditions added to the list are as follows:

  • Acute coronary syndrome (ACS);
  • Atrial fibrillation (AF);
  • Coronary heart disease;
  • Epilepsy;
  • Glaucoma;
  • Gout;
  • Heart failure;
  • Hypercholesterolaemia ;
  • Long term risks of venous thromboembolism/embolism;
  • Osteoporosis;
  • Parkinson’s Disease;
  • Stroke / transient ischemic attack; and
  • Urinary incontinence and retention

Click here for further details 

NMS and Transitional Payments – Important Funding Update

We have been made aware that some contractors have not picked up on the change of transitional payments relating to NMS provision – please take note of the changes communicated last year as part of the funding arrangements and ensure that you have claimed for at least ONE NMS in the previous month to ensure that you can receive the transition payment.

Contractors will only be eligible for the service delivery part of the transitional payment if they have claimed for at least one New Medicine Service (NMS) in the previous month; and been registered to provide the Community Pharmacy Consultation Service (CPCS) on the Manage Your Service (MYS) platform for greater than or equal to half of the number of full days in the previous month.

Full guidance can be found here.
The CPE update can be found here.

Further information on the service can be found on the CPE website

 

NMS - Depression Pilot - August 2022 - 31 March 2024

The aim of the pilot is to test the inclusion of depression as a therapeutic area in the NMS and to test a revised NMS service model that would align more closely with the treatment of depression in primary care as part of an integrated clinical pathway. The service will also provide an opportunity to better utilise community pharmacists in supporting patients with mental health conditions.

Subject to the results of the pilot evaluation, this work will inform the further expansion of NMS therapeutic areas and a more flexible, patient-centric service model that aims to be better integrated into local care pathways, enabled by enhanced local signposting and data sharing.

 

Key documents

NMS Expansion Pilot SLA-ServiceSpec FINAL v1.0

NMS anti_depressant_pilot_patient feedback_A5_flyer_V1

NMS Depression Pilot Weekly Updates issue 1 22-08-2023

NMS Depression Pilot Weekly Updates issue 2 11-09-2023

NMS Depression Weekly Pilot Updates issue 3 29-09-2023

NMS Depression Pilot Updates issue 4 15-11-2023

NMS Depression Pilot Updates issue 5 28-11-2023

 

NMS Depression Pilot Webinar

In order to support you to deliver this pilot a webinar was recently hosted by GM Healthcare Academy.

Click the link to watch on demand: NMS Depression Pilot Webinar – November 2023